Incyte Earnings: Here’s Why Investors are Not Happy Now

Incyte Corporation (NASDAQ:INCY) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 2.70%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Incyte Corporation Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased to $-0.12 in the quarter versus EPS of $-0.36 in the year-earlier quarter.

Revenue: Rose 96.52% to $71.1 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Incyte Corporation reported adjusted EPS loss of $0.12 per share. By that measure, the company beat the mean analyst estimate of $-0.2. It beat the average revenue estimate of $68.16 million.

Quoting Management: “We continue to see solid growth for Jakafi, which means that more patients are experiencing the benefits of the first FDA-approved treatment for intermediate or high-risk myelofibrosis,” stated Paul A. Friedman, M.D., Incyte’s President and Chief Executive Officer. “Additionally, as we gain important visibility into several mid-stage trials, we continue to broaden the scope of our R&D efforts, as evidenced by the introduction of a second JAK1 inhibitor into clinical development.”

Key Stats (on next page)…

Revenue decreased 37.55% from $113.85 million in the previous quarter. EPS decreased to $-0.12 in the quarter versus EPS of $0.14 in the previous quarter.

Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a loss of $0.05 to a loss $0.01. For the current year, the average estimate has moved up from a loss of $0.4 to a loss of $0.35 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]